CCL22
C-C motif chemokine 22
Also known as: A-152E5.1, ABCD-1, CCL22_HUMAN, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00626
- Gene
- CCL22
- Ensembl
- ENSG00000102962
- Chromosome
- 16
- Canonical length
- 93 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, dendritic cells, natural killer cells and for chronically activated T lymphocytes. It also displays a mild activity for primary activated T lymphocytes and has no chemoattractant activity for neutrophils, eosinophils and resting T lymphocytes. The product of this gene binds to chemokine receptor CCR4. This chemokine may play a role in the trafficking of activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
93 residues, UniProt reviewed canonical sequence.
>O00626|CCL22
1 MDRLQTALLV VLVLLAVALQ ATEAGPYGAN MEDSVCCRDY VRYRLPLRVV KHFYWTSDSC
61 PRPGVVLLTF RDKEICADPR VPWVKMILNK LSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCL22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- thymus: 14 nTPM
- tonsil: 14 nTPM
- appendix: 13 nTPM
- skin: 6.2 nTPM
- lymph node: 5.5 nTPM
- rectum: 5.1 nTPM
Single-cell type
- cdc: 160 nCPM
- macrophages: 15 nCPM
- suprabasal keratinocytes: 4.1 nCPM
- monocytes: 3.8 nCPM
- breast secretory cells: 2.7 nCPM
- foveolar cells: 2.5 nCPM
Immune cell
- basophil: 1.2 nTPM
- neutrophil: 1.1 nTPM
- memory B-cell: 1 nTPM
- myeloid DC: 0.9 nTPM
- naive B-cell: 0.4 nTPM
- NK-cell: 0.3 nTPM
Brain region
- cerebellum: 4.5 nTPM
- white matter: 4.4 nTPM
- choroid plexus: 3.9 nTPM
- pons: 3.7 nTPM
- basal ganglia: 3.6 nTPM
- cerebral cortex: 3.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCL22.
Disease | ImmuneIEDB
Conditions an epitope on CCL22 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cell chemotaxis
- cell-cell signaling
- chemokine-mediated signaling pathway
- chemotaxis
- eosinophil chemotaxis
- immune response
- inflammatory response
- positive regulation of cell migration
- response to virus
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCL22 as an antibody target. Whether an autoantibody or antibody against CCL22 could matter depends on whether native CCL22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCL22 is annotated as secreted, so native CCL22 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CCL22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...